Investor Diligence
Assessment of clinical validity, adoption pathway, evidence strength, reimbursement context, stakeholder influence, and commercial durability.
- Target diligence memo
- Evidence and workflow risk review
- Market and stakeholder map
- Competitive position assessment
- Red flag and confirmatory diligence questions